Skystar Bio-Pharmaceutical (SKBI) Stock Price, News & Analysis

Company Overview

Skystar Bio-Pharmaceutical Company researches, develops, produces, markets, and sells veterinary healthcare and medical care products in the People's Republic of China. The company offers micro-organism products, veterinary medicines for poultry and livestock, feed additives, and bio-pharmaceutical veterinary vaccines. It markets its products through distributers and franchise distributors, as well as directly to customers. The company is headquartered in Xi'an, the People's Republic of China.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 25 shs
• Average Volume: 1,983 shs
• Market Capitalization: $1 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SKBI Stock Analysis - Frequently Asked Questions

How do I buy shares of Skystar Bio-Pharmaceutical?

Shares of SKBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Skystar Bio-Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Skystar Bio-Pharmaceutical investors own include Inovio Pharmaceuticals (INO), SES AI (SES), FuelCell Energy (FCEL), Kopin (KOPN), Remark (MARK) and American Battery Technology (ABAT).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:SKBI
• Previous Symbol: NASDAQ:SKBI
• CIK: 1076939
• Web: www.skystarbio-pharmaceutical.com
• Phone: 86-29-8819-3188
• Fax: N/A
• Employees: 317
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 8,700,000
• Free Float: N/A
• Market Cap: $1 thousand
• Optionable: Not Optionable
• Beta: -175.12